Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

David T. Jones | Sheng-Yang M. Goh | A. Toga | L. Petrucelli | J. Trojanowski | K. Rankin | B. Dickerson | C. Lungu | J. Graff‐Radford | B. Boeve | D. Knopman | K. Kantarci | L. Shaw | M. Grossman | W. Kremers | D. Kaufer | J. Kramer | S. Weintraub | W. Kukull | H. Rosen | S. McGinnis | T. Foroud | G. Coppola | F. Elahi | A. Boxer | A. Karydas | J. Kornak | E. Huey | I. Litvan | H. Heuer | G. Hsiung | Z. Wszolek | N. Graff-Radford | D. Irwin | K. Rascovsky | K. Domoto-Reilly | E. Rogalski | E. Roberson | I. Mackenzie | M. Tartaglia | M. Mendez | C. Onyike | A. Staffaroni | Jaya Padmanabhan | D. Lucente | D. Kerwin | L. Jones | R. Gavrilova | N. Ghoshal | J. Fields | Namita Multani | P. Sengdy | E. Ramos | Christina M. Dheel | J. Goldman | J. Bove | D. Brushaber | S. Dickinson | J. Fong | L. Forsberg | D. Gearhart | D. Haley | M. Manoochehri | R. Pearlman | M. Potter | J. Syrjanen | N. Tatton | Joanne B. Taylor | B. Wong | K. Casaletto | Y. Cobigo | C. Caso | A. Pantelyat | Y. Bordelon | Lynn P. Bajorek | P. Ljubenkov | B. Appleby | A. Wolf | Jeremy A. Syrjanen | P. Brannelly | E. McKinley | I. Grant | Kelly Faber | J. Ferrall | A. Fishman | B. Ghazanfari | R. Kraft | M. Maldonado | R. Rademakers | B. Miller | Ping Wang | Reilly Dever | Sophia Dominguez | Emily C. McKinley | Peter A. Ljubenkov | B. Miller | Pheth Sengdy | Madeleine Potter | Masood Manoochehri | Rodney Pearlman | Sheng‐Yang M. Goh | Patrick Brannelly | Jessica Ferrall | Ann Fishman | Debra J. Gearhart | Behnaz Ghazanfari | Dana Haley | Ruth A. Kraft | Miranda Maldonado | Bonnie Wong | D. Knopman | M. Grossman | Danielle E. Brushaber | Amy Wolf | Kimiko Domoto-Reilly | Alexander Y. Pantelyat | Danielle Brushaber | Jamie C. Fong

[1]  David T. Jones,et al.  Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration , 2019, Alzheimer's & Dementia.

[2]  B. Miller,et al.  Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials , 2019, Brain : a journal of neurology.

[3]  J. V. van Swieten,et al.  Longitudinal cognitive biomarkers predicting symptom onset in presymptomatic frontotemporal dementia , 2018, Journal of Neurology.

[4]  J. V. van Swieten,et al.  Meta-analytic Review of Memory Impairment in Behavioral Variant Frontotemporal Dementia , 2018, Journal of the International Neuropsychological Society.

[5]  Hiroko H. Dodge,et al.  Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS) , 2017, Alzheimer disease and associated disorders.

[6]  R. Bateman,et al.  Stop Alzheimer’s before it starts , 2017, Nature.

[7]  J. Morris,et al.  The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement , 2017, Alzheimer's & Dementia.

[8]  R. Laforce,et al.  Dysexecutive Symptoms in Primary Progressive Aphasia: Beyond Diagnostic Criteria , 2017, Journal of geriatric psychiatry and neurology.

[9]  J. V. van Swieten,et al.  Presymptomatic cognitive decline in familial frontotemporal dementia , 2016, Neurology.

[10]  J. Rohrer,et al.  The clinical spectrum of sporadic and familial forms of frontotemporal dementia , 2016, Journal of neurochemistry.

[11]  A. Boxer,et al.  Therapy and clinical trials in frontotemporal dementia: past, present, and future , 2016, Journal of Neurochemistry.

[12]  D. Hill,et al.  Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials , 2016, Alzheimer's Research & Therapy.

[13]  Anjali N Patel,et al.  Cognitive Profile of C9orf72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis , 2015, Current Neurology and Neuroscience Reports.

[14]  Veronica Redaelli,et al.  Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis , 2015, The Lancet Neurology.

[15]  J. Kramer,et al.  Memory Profiles in Pathology or Biomarker Confirmed Alzheimer Disease and Frontotemporal Dementia , 2014, Alzheimer disease and associated disorders.

[16]  H. Feldman,et al.  Early Neuropsychological Characteristics of Progranulin Mutation Carriers , 2014, Journal of the International Neuropsychological Society.

[17]  J. Karlawish,et al.  The A4 Study: Stopping AD Before Symptoms Begin? , 2014, Science Translational Medicine.

[18]  Ron Dumont,et al.  California Verbal Learning Test, Second Edition , 2014 .

[19]  Nick C Fox,et al.  Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. , 2014, The New England journal of medicine.

[20]  Howard J. Rosen,et al.  NIH EXAMINER: Conceptualization and Development of an Executive Function Battery , 2013, Journal of the International Neuropsychological Society.

[21]  J. Kramer,et al.  Ecological Validity and Neuroanatomical Correlates of the NIH EXAMINER Executive Composite Score , 2013, Journal of the International Neuropsychological Society.

[22]  K. Rankin,et al.  Dissociable executive functions in behavioral variant frontotemporal and Alzheimer dementias , 2013, Neurology.

[23]  N. Balluerka,et al.  Neuropsychological Features of Asymptomatic c.709-1G>A Progranulin Mutation Carriers* , 2012, Journal of the International Neuropsychological Society.

[24]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.

[25]  Tushar Sakpal,et al.  Sample Size Estimation in Clinical Trial , 2010, Perspectives in clinical research.

[26]  Nick C Fox,et al.  The heritability and genetics of frontotemporal lobar degeneration , 2009, Neurology.

[27]  Nathaniel Mercaldo,et al.  Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. , 2008, Brain : a journal of neurology.

[28]  Howard J. Rosen,et al.  Distinctive Neuropsychological Patterns in Frontotemporal Dementia, Semantic Dementia, And Alzheimer Disease , 2003, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[29]  B. Reed,et al.  Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons. , 2003, Neuropsychology.

[30]  T. Ferman,et al.  Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation. , 2003, Parkinsonism & related disorders.

[31]  D. Geschwind,et al.  Dementia and neurodevelopmental predisposition: Cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia , 2001, Annals of neurology.

[32]  R. Hambleton,et al.  Fundamentals of Item Response Theory , 1991 .